Notice: Undefined index: HTTP_ACCEPT_LANGUAGE in /home/stockstowatch/public_html/wp-content/mu-plugins/GrULw0.php on line 4

Notice: Undefined index: HTTP_ACCEPT_LANGUAGE in /home/stockstowatch/public_html/wp-content/mu-plugins/GrULw0.php on line 4
Uxin, Heidrick & Struggles International And 3 Stocks To Watch Heading Into Friday – Dermata Therapeutics (NASDAQ:DRMA), Heidrick & Struggles Intl (NASDAQ:HSII) – Stocks to Watch
  • Wed. May 15th, 2024

Uxin, Heidrick & Struggles International And 3 Stocks To Watch Heading Into Friday – Dermata Therapeutics (NASDAQ:DRMA), Heidrick & Struggles Intl (NASDAQ:HSII)

ByLisa Levin

Dec 30, 2022
Uxin, Heidrick & Struggles International And 3 Stocks To Watch Heading Into Friday - Dermata Therapeutics (NASDAQ:DRMA), Heidrick & Struggles Intl (NASDAQ:HSII)

[ad_1]

With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:

  • Uxin Limited UXIN is expected to report its unaudited financial results for the second quarter of fiscal year 2023 before the opening bell. Uxin shares gained 4.4% to $3.30 in the after-hours trading session.
  • Mesa Air Group, Inc. MESA reported a wider-than-expected loss for its fourth quarter, while sales topped estimates. Mesa Air shares dropped 2.2% to $1.32 in after-hours trading.
  • Heidrick & Struggles International, Inc. HSII agreed to acquire Atreus for $61 million. Heidrick & Struggles shares gained 1.5% to $28.92 in after-hours trading.

Check out our premarket coverage here

  • Sesen Bio, Inc. SESN and Carisma Therapeutics reported an increased special dividend of approximately $0.34 per share, in connection with the pending merger. Sesen Bio shares surged 30.5% to $0.6589 in the after-hours trading session.
  • Dermata Therapeutics, Inc. DRMA requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering. Dermata Therapeutics shares jumped 135% to $0.47 in after-hours trading.

Read This Next: Paychex And 2 Other Stocks Insiders Are Selling

[ad_2]

Image and article originally from www.benzinga.com. Read the original article here.